ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

Zeneca Buys 50% Stake In Salick, Gets Managed Care Access

January 6, 1995

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992

Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards

February 12, 1999

DCE Concepts Statements

March 11, 1988

In Brief: FDA Seeks Applicants For Oncology Div. Head; Croce Wins Pasarow Award; CRI Honors Five

August 18, 1995

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010